Each year, over 1 million Americans are admitted to hospitals with heart failure (HF) as the primary discharge diagnosis [1]. Hospitalization for acute decompensated HF (ADHF) represents a critical turning point in the natural progression of chronic HF, markedly elevating subsequent risk of mortality [2]. While several risk prediction models and individual indicators for prognosis exist [3], systolic blood pressure (SBP) remains a dominant predictor of incident HF and has the potential to impact subsequent mortality [4,5].
